296 related articles for article (PubMed ID: 2190769)
1. Failure of nocturnal hypoglycemia to cause daytime hyperglycemia in patients with IDDM.
Hirsch IB; Smith LJ; Havlin CE; Shah SD; Clutter WE; Cryer PE
Diabetes Care; 1990 Feb; 13(2):133-42. PubMed ID: 2190769
[TBL] [Abstract][Full Text] [Related]
2. Failure of nocturnal hypoglycemia to cause fasting hyperglycemia in patients with insulin-dependent diabetes mellitus.
Tordjman KM; Havlin CE; Levandoski LA; White NH; Santiago JV; Cryer PE
N Engl J Med; 1987 Dec; 317(25):1552-9. PubMed ID: 3317053
[TBL] [Abstract][Full Text] [Related]
3. Hypoglycemia-induced autonomic failure in IDDM is specific for stimulus of hypoglycemia and is not attributable to prior autonomic activation.
Rattarasarn C; Dagogo-Jack S; Zachwieja JJ; Cryer PE
Diabetes; 1994 Jun; 43(6):809-18. PubMed ID: 8194668
[TBL] [Abstract][Full Text] [Related]
4. Nocturnal blood glucose control in type I diabetes mellitus.
Bolli GB; Perriello G; Fanelli CG; De Feo P
Diabetes Care; 1993 Dec; 16 Suppl 3():71-89. PubMed ID: 8299480
[TBL] [Abstract][Full Text] [Related]
5. Glucoregulation during exercise: hypoglycemia is prevented by redundant glucoregulatory systems, sympathochromaffin activation, and changes in islet hormone secretion.
Hoelzer DR; Dalsky GP; Clutter WE; Shah SD; Holloszy JO; Cryer PE
J Clin Invest; 1986 Jan; 77(1):212-21. PubMed ID: 3511090
[TBL] [Abstract][Full Text] [Related]
6. Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia.
Dagogo-Jack SE; Craft S; Cryer PE
J Clin Invest; 1993 Mar; 91(3):819-28. PubMed ID: 8450063
[TBL] [Abstract][Full Text] [Related]
7. Reversal of hypoglycemia unawareness, but not defective glucose counterregulation, in IDDM.
Dagogo-Jack S; Rattarasarn C; Cryer PE
Diabetes; 1994 Dec; 43(12):1426-34. PubMed ID: 7958494
[TBL] [Abstract][Full Text] [Related]
8. Glucagon, not insulin, may play a secondary role in defense against hypoglycemia during exercise.
Tuttle KR; Marker JC; Dalsky GP; Schwartz NS; Shah SD; Clutter WE; Holloszy JO; Cryer PE
Am J Physiol; 1988 Jun; 254(6 Pt 1):E713-9. PubMed ID: 3287952
[TBL] [Abstract][Full Text] [Related]
9. Early-morning hyperglycemia in IDDM. Acute effects of cholinergic blockade.
Atiea JA; Creagh F; Page M; Owens DR; Scanlon MF; Peters JR
Diabetes Care; 1989; 12(7):443-8. PubMed ID: 2667925
[TBL] [Abstract][Full Text] [Related]
10. Contribution of autonomic neuropathy to reduced plasma adrenaline responses to hypoglycemia in IDDM: evidence for a nonselective defect.
Bottini P; Boschetti E; Pampanelli S; Ciofetta M; Del Sindaco P; Scionti L; Brunetti P; Bolli GB
Diabetes; 1997 May; 46(5):814-23. PubMed ID: 9133549
[TBL] [Abstract][Full Text] [Related]
11. The effect of asymptomatic nocturnal hypoglycemia on glycemic control in diabetes mellitus.
Perriello G; De Feo P; Torlone E; Calcinaro F; Ventura MM; Basta G; Santeusanio F; Brunetti P; Gerich JE; Bolli GB
N Engl J Med; 1988 Nov; 319(19):1233-9. PubMed ID: 3054544
[TBL] [Abstract][Full Text] [Related]
12. Attenuated glucose recovery from hypoglycemia in the elderly.
Marker JC; Cryer PE; Clutter WE
Diabetes; 1992 Jun; 41(6):671-8. PubMed ID: 1587394
[TBL] [Abstract][Full Text] [Related]
13. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.
Pampanelli S; Torlone E; Ialli C; Del Sindaco P; Ciofetta M; Lepore M; Bartocci L; Brunetti P; Bolli GB
Diabetes Care; 1995 Nov; 18(11):1452-9. PubMed ID: 8722069
[TBL] [Abstract][Full Text] [Related]
14. Exaggerated epinephrine response to hypoglycemia in a physically fit, well-controlled IDDM subject.
Davis SN; Goldstein RE; Cherrington AD; Price L
Diabetes Res Clin Pract; 1994 Jan; 22(2-3):139-46. PubMed ID: 8200295
[TBL] [Abstract][Full Text] [Related]
15. Hypoinsulinemia is not critical to glucose recovery from hypoglycemia in humans.
Heller SR; Cryer PE
Am J Physiol; 1991 Jul; 261(1 Pt 1):E41-8. PubMed ID: 1858873
[TBL] [Abstract][Full Text] [Related]
16. Alanine and terbutaline in treatment of hypoglycemia in IDDM.
Wiethop BV; Cryer PE
Diabetes Care; 1993 Aug; 16(8):1131-6. PubMed ID: 8375243
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis of the dawn phenomenon in patients with insulin-dependent diabetes mellitus. Accelerated glucose production and impaired glucose utilization due to nocturnal surges in growth hormone secretion.
Campbell PJ; Bolli GB; Cryer PE; Gerich JE
N Engl J Med; 1985 Jun; 312(23):1473-9. PubMed ID: 2859524
[TBL] [Abstract][Full Text] [Related]
18. Glucose counterregulation and waning of insulin in the Somogyi phenomenon (posthypoglycemic hyperglycemia).
Bolli GB; Gottesman IS; Campbell PJ; Haymond MW; Cryer PE; Gerich JE
N Engl J Med; 1984 Nov; 311(19):1214-9. PubMed ID: 6387483
[TBL] [Abstract][Full Text] [Related]
19. Absence of the dawn phenomenon and abnormal lipolysis in type 1 (insulin-dependent) diabetic patients with chronic growth hormone deficiency.
Boyle PJ; Avogaro A; Smith L; Shah SD; Cryer PE; Santiago JV
Diabetologia; 1992 Apr; 35(4):372-9. PubMed ID: 1516766
[TBL] [Abstract][Full Text] [Related]
20. Role of epinephrine-mediated beta-adrenergic mechanisms in hypoglycemic glucose counterregulation and posthypoglycemic hyperglycemia in insulin-dependent diabetes mellitus.
Popp DA; Shah SD; Cryer PE
J Clin Invest; 1982 Feb; 69(2):315-26. PubMed ID: 6120181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
